Data / Form D filings / Rakuten Medical, Inc.
Rakuten Medical, Inc.: Form D filing
Rakuten Medical, Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2026. The latest, on October 6, 2026, reports $9 million sold of a $9 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6885 Flanders Drive Suite 1000, San Diego, CA, 92121
- Phone
- (858) 925-5619
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1595215
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6 | New notice | $8,974,943 | $8,974,943 | 14 | Aug 16 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maeda Minami | Executive Officer | |
| David Chao | Director | |
| Miguel Garcia-Guzman | Director | |
| Hiroshi Mikitani | Director | |
| Hiroshi Mori | Director | |
| Ken Takeshita | Director | |
| Christophe Weber | Director | |
| Nitin Nohria | Director | |
| Eiichi Kaga | Director | |
| Mazen Darwazeh | Director | |
| Tiffany Piecewicz | Executive Officer | |
| Abhijit Bhatia | Executive Officer | |
| Toshiaki Suzuki | Executive Officer | |
| Suzane San | Executive Officer | |
| Hiroyuki Kodama | Executive Officer | |
| Louise Chang | Executive Officer | |
| Amy Thorne | Executive Officer | |
| Anthony Manibusan | Executive Officer | |
| Hassan Danesi | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
Every Form D from the week of Oct 5 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rakuten Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.